Allegra Freelander 35th Lorne Cancer Conference 2023

Abstracts this author is presenting:

• Selective androgen receptor modulators in combination with CDK4/6 inhibitors demonstrate anti-cancer activity in preclinical treatment resistant ER+AR+ breast cancer models — Welcome Function & Poster Session I